, /PRNewswire/ -- The global emergency contraceptive pills market size is estimated to grow by million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 4.36% during the forecast period.
rise in number of initiatives to create awareness is driving market growth, with a trend towards importance of family planning. However, local governments limiting access to emergency contraceptive pills poses a challenge. Key market players include AbbVie Inc.
, Afaxys Pharma LLC, Bayer AG, Combe Inc., Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Ltd., Knoll Healthcare Pvt.
Ltd., Laboratoire HRA Pharma SAS, Lupin Ltd., Mankind Pharma Ltd.
, Morepen Laboratories Ltd., Perrigo Co. Plc, Pfizer Inc.
, Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Syzygy Healthcare LLC, and Teva Pharmaceutical Industries Ltd.
. Get a detailed analysis on regions, market segments, customer landscape, and companies- The Emergency Contraceptive Pills (ECPs) market is witnessing significant growth due to increasing awareness about family planning in both developed and developing countries. Organizations like the Asia Pacific Council on Contraception, European Society of Cardiology, and International Planned Parenthood Federation are promoting the use of ECPs to prevent unplanned pregnancies and related health risks.
In developing countries, where there is a high unmet need for contraception, government initiatives and easy access to ECPs are incre.
